Key result
Genetic variants in JAK2, TTN, TET2, and ATM were identified as the most highly interconnected shared risk factors for cancer and cardiovascular diseases, with significant enrichment in DNA damage repair pathways.
Why the study?
While cancer and cardiovascular diseases share common environmental risk factors, their shared genetic risk factors are not yet fully understood.
Systematic Review (n=13)
Shared genetic risk factors between cancer and cardiovascular diseases are significantly enriched in DNA damage repair pathways, highlighting potential common pathophysiological mechanisms.
Does not yet alter cardio-oncology practice; leaves open validation of these variants for risk stratification or targeted therapy.
Cancer and cardiovascular diseases (CVD) account for approximately 27.5 million deaths every year. While they share some common environmental risk factors, their shared genetic risk factors are not yet fully understood. The aim of the present study was to aggregate genetic risk factors associated with the comorbidity of cancer and CVDs. For this purpose, we: (1) created a catalog of genes associated with cancer and CVDs, (2) visualized retrieved data as a gene-disease network, and (3) performed a pathway enrichment analysis. We performed screening of PubMed database for literature reporting genetic risk factors in patients with both cancer and CVD. The gene-disease network was visualized using Cytoscape and the enrichment analysis was conducted using Enrichr software. We manually reviewed the 181 articles fitting the search criteria and included 13 articles in the study. Data visualization revealed a highly interconnected network containing a single subnetwork with 56 nodes and 146 edges. Genes in the network with the highest number of disease interactions were JAK2 , TTN, TET2 , and ATM . The pathway enrichment analysis revealed that genes included in the study were significantly enriched in DNA damage repair (DDR) pathways, such as homologous recombination. The role of DDR mechanisms in the development of CVDs has been studied in previously published research; however, additional functional studies are required to elucidate their contribution to the pathophysiology to CVDs.
No takes yet. Share an insight, caveat, or question.
Turk et al. (2022) conducted a systematic review in Cancer and Cardiovascular Diseases (n=13). Genetic variants (JAK2, TTN, TET2, ATM) was evaluated on Identification of shared genetic risk factors and pathway enrichment. Genetic variants in JAK2, TTN, TET2, and ATM were identified as the most highly interconnected shared risk factors for cancer and cardiovascular diseases, with significant enrichment in DNA damage repair pathways.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: